Medibank Private Limited is a health company based in Australia that specializes in private health insurance and health-related services. The company operates primarily through two brands, Medibank and ahm, offering a variety of health insurance products. Its Health Insurance segment provides both hospital and ancillary coverage. Hospital cover ensures that members have financial support for various hospital treatments while ancillary cover is for other healthcare services like dental, optical, and physiotherapy.
Alongside insurance, Medibank’s Health segment offers health management and home care services, as well as telehealth services across Australia. It caters not only to individuals but also has agreements with government and corporate clients. Additionally, Medibank extends its product range by distributing travel, life, and pet insurance policies, which are provided by other insurers.
Overview
Medibank Private combines a large Australian private health-insurance business with a growing range of care and health services. Its revenue growth and 4.26% dividend yield are part of the investment picture, but so are the cost of claims, competition and the challenge of maintaining profitability. At A$4.53, the shares sat below both their 50-day and 200-day moving averages, adding a softer recent price trend to the fundamental considerations.
Medibank Private is an Australian health insurer with a substantial presence in private health cover through its Medibank and ahm brands. Its core business spans hospital and ancillary cover for residents and non-residents. Alongside insurance, the company provides health management, telehealth, primary care and in-home care services, and distributes travel, life and pet insurance. This combination links its earnings to both insurance membership and the delivery of health-related services.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
Key facts
- Ticker
- MPL
- Exchange
- AU
- ISIN
- AU000000MPL3
- Sector
- Financial Services
- Industry
- Insurance – Specialty
- Country
- Australia
- Currency
- AUD
- Price
- A$4.53
- Previous close
- A$4.51
- Day change
- +A$0.02 (+0.44%)
- Market cap
- 12.5B
- 52W low
- A$3.97
- 52W high
- A$5.19
Price and trend
Last price: A$4.53
- Price
- A$4.53
- 52W range
- A$3.97 – A$5.19
- 50-day SMA
- A$4.85
- 200-day SMA
- A$4.71
- Price vs 50D SMA
- -6.58%
- Price vs 200D SMA
- -3.86%
Valuation
- P/E
- 19.70
- PEG
- 0.00
- EPS
- 0.23
- Dividend yield
- 4.26%
- Beta
- 0.05
Medibank’s market capitalisation is 12.5B and its price-to-earnings ratio is 19.7, placing the focus on whether the insurer can sustain earnings as it grows its revenue and health services. The supplied dividend yield of 4.26% adds an income component, but dividends are not assured. A supplied target price of A$5.00 is 10.38% from the last price; it is best treated as secondary context rather than a measure of the company’s underlying value.
Profitability and growth
- Revenue growth
- 12.60%
- Revenue TTM
- 9.3B
- Profit margin
- 6.87%
Analyst view
Comparison uses the last price shown; targets are analyst estimates.
- Price
- A$4.53
- Target price
- A$5.00
- Target vs last price
- 10.38% from last price
The business has reported revenue growth of 12.60%, with revenue of 9.3B and a profit margin of 6.87%. That points to a sizeable operation, although revenue growth alone does not establish whether profitability will strengthen. The share price was A$4.53, within its 52-week range of A$3.97 to A$5.19, and below its 50-day and 200-day moving averages. Those measures offer technical context alongside the more important questions of membership, claims costs and sustainable returns.
Risks
Medibank’s performance depends heavily on retaining policyholders and balancing premium income against the cost of claims and delivering care. Competition, changes to health-insurance rules and pressure on household budgets could affect membership, pricing or profitability. Its broader health services also expose it to operational and execution risks. The shares were below both supplied moving averages, while their 52-week range of A$3.97 to A$5.19 shows that the price has moved across a meaningful range.
FAQ
What does Medibank Private do?
Medibank provides private health insurance through its Medibank and ahm brands, including hospital and extras cover. It also offers health management, telehealth, primary care and in-home care services, and distributes travel, life and pet insurance.
How has Medibank’s share price compared with its moving averages?
At A$4.53, the share price was 6.58% below its 50-day moving average of A$4.85 and 3.86% below its 200-day moving average of A$4.71. These measures provide recent price context but do not determine future performance.
What is Medibank’s dividend yield?
The supplied dividend yield is 4.26%. Dividends can change and are not guaranteed.
*This content is aimed to provide general information only, and does not take your personal objectives, financial situation or needs into account.
Medibank Private Limited (ASX: MPL) Fundamentals
